MedTrace Logo

The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption

NCT03883503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-05-15

No results posted yet for this study

Summary

The main interest of this study is to investigate the influence of moderate alcohol consumption (beer) on salt-water homeostasis. Therefore, 10 healthy volunteers will participate in 4 Intervention:

* Beer alone
* Beer and water
* Beer and salt (stock/bouillon)
* Water alone During the study day, copeptin, sodium, osmolality and urinary sodium/osmolality will be measured at 6 timepoints.

Conditions

  • Alcohol Drinking

Interventions

OTHER

Beer 5%o

Weight adjusted beer to reach 0.8 blood alcohol content will be given over the time course of 1 hour to the participants

OTHER

Beer 8.5%o and water

Weight adjusted beer to reach 0.8 blood alcohol content and water will be given over the time course of 1 hour to the participants

OTHER

Beer 8.5%o and stock

Weight adjusted beer to reach 0.8 blood alcohol content and stock will be given over the time course of 1 hour to the participants

OTHER

Water

Water equivalent to the calculated volume of beer will be given over the time course of 1 hour to the participants

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. Dr. MD · University Hospital, Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2019-04-10
Completion
2019-04-10

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03883503 on ClinicalTrials.gov